Trial Profile
Observation of Change in Clinical Global Impression Scores in Schizophrenia Patients Receiving Seroquel XR Treatment.
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 15 Dec 2010
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 09 Dec 2010 Actual end date changed from Dec 2008 to Mar 2009 as reported by ClinicalTrials.gov.
- 24 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jun 2009 Actual end date (December 2008) added as reported by ClinicalTrials.gov.